Highlights ArcticZymes Technologies ASA

Equities

AZT

NO0010014632

Market Closed - Oslo Bors Other stock markets 08:15:00 15/05/2024 pm IST			5-day change	1st Jan Change
23.65 ^NOK	0.00%		-0.42%	-43.69%

13/05	ArcticZymes Technologies ASA Announces Board Resignations	CI
08/05	ArcticZymes Technologies ASA Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ArcticZymes Technologies ASA Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05	CI
Norway's ArcticZymes Teams Up With Austrian Group for Bionanoparticles Research Project	09/04	MT
ArcticZymes Technologies ASA Initiates Joint Research Project with Austrian Centre of Industrial Biotechnology	09/04	CI
ArcticZymes Technologies ASA Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	01/02	CI
ArcticZymes Technologies ASA Reports Earnings Results for the Full Year Ended December 31, 2023	01/02	CI
Arcticzymes Technologies Asa Announces the Launch of Its First Gmp-Grade Product, San Hq	30/01	CI
Norway’s ArcticZymes Technologies Manufactures GMP-grade Enzyme	30/01	MT
ArcticZymes Technologies ASA Launches T7 RNA Polymerase	21/12	CI
ArcticZymes Technologies ASA Enters into an Agreement with Biomatter	19/12	CI
ArcticZymes Technologies ASA Announces Partnership with Biomatter	19/12	CI
ArcticZymes Technologies ASA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	02/11	CI
ArcticZymes Technologies ASA Announces DMF for SAN HQ GMP accepted by the US FDA	21/23/21	CI
ArcticZymes Technologies ASA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	17/23/17	CI
ArcticZymes Technologies ASA Launches Taq?? DNA Polymerase	10/23/10	CI
ArcticZymes Technologies Files DMF for SAN HQ GMP	29/23/29	CI
ArcticZymes Technologies ASA Reports Earnings Results for the First Quarter Ended March 31, 2023	04/23/04	CI
ArcticZymes Technologies ASA Reports Earnings Results for the First Quarter Ended March 31, 2023	04/23/04	CI
ArcticZymes Technologies ASA and Genovis AB Announce Collaboration to Speed Up Penetration and Growth in the Chinese Market	03/23/03	CI
ArcticZymes Technologies ASA Launches ArcticZymes Proteinase HQ	18/23/18	CI
Norway's ArcticZymes Files New RNA-based Therapeutics Patent Application	16/23/16	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights ArcticZymes Technologies ASA

Equities

AZT

NO0010014632

Highlights

Filters